泰恩康(301263.SZ)：地诺孕素片境内生产药品注册上市许可申请获受理

Group 1 - The company TianKang (301263.SZ) announced that its wholly-owned subsidiary Anhui TianKang Pharmaceutical Co., Ltd. has recently received the "Acceptance Notice" for the domestic production drug registration application for Dienogest tablets from the National Medical Products Administration [1] - Dienogest is a selective progestin used for the treatment of endometriosis, which can alleviate pain symptoms and stabilize endometrial tissue, with advantages of good tolerance and low adverse reaction rates [1]